Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Imagion Biosystems Ltd. ( (AU:IBX) ) has issued an update.
Imagion Biosystems Ltd. has announced the quotation of 12,292,437 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of September 30, 2025. This move reflects the conversion of options or other convertible securities, potentially enhancing the company’s liquidity and market presence.
More about Imagion Biosystems Ltd.
Imagion Biosystems Ltd. operates in the biotechnology industry, focusing on the development of diagnostic imaging technology. The company specializes in non-radioactive detection systems aimed at improving the early detection of cancer.
Average Trading Volume: 10,566,751
Technical Sentiment Signal: Buy
Current Market Cap: A$16.66M
Find detailed analytics on IBX stock on TipRanks’ Stock Analysis page.